Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK
- 22 October 2004
- journal article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 12 (1), 101-108
- https://doi.org/10.1038/sj.cgt.7700779
Abstract
In order to noninvasively detect Salmonella delivery vectors within tumors, we used a genetically modified Salmonella, VNP20009, that expresses the herpes simplex thymidine kinase (HSV1-tk) reporter gene. VNP20009-TK were able to selectively localize within murine tumor models and to effectively sequester a radiolabeled nucleoside analogue, 2'-fluoro-1--D-arabino-furanosyl-5-iodo-uracil (FIAU). A quantitative relationship between the level of radioactivity accumulated and the number of bacteria in tumor and different tissues was demonstrated. The in vivo accumulation of [14C]FIAU measured in tissue sample homogenates and sections were related to Salmonella number and to immunohistochemical bacterial staining, respectively. Quantitative autoradiography (QAR) revealed the relative intensity of [14C]FIAU accumulation in a tumor cross-section, demonstrating that the peripheral region of the tumor was significantly less active than internal regions. [124I]FIAU positron emission tomography (PET) and subsequent tissue radioactivity and bacterial concentration measurements were compared. A log–log relationship was found, and the PET images could identify multiple tumor sites. The ability to noninvasively detect Salmonella vectors by PET imaging has the potential to be conducted in a clinical setting, and could aid in development of these vectors by demonstrating the efficiency and duration of targeting as well as indicating the locations of tumors.Keywords
This publication has 37 references indexed in Scilit:
- Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteinsNature Biotechnology, 2004
- Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: Selective inhibitor of angiogenesis and hypoxic tumor growthCancer Gene Therapy, 2003
- Antitumor Effects in Mice of the Intravenous Injection of Attenuated Salmonella TyphimuriumJournal of Immunotherapy, 2002
- Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosisGene Therapy, 2002
- Combination bacteriolytic therapy for the treatment of experimental tumorsProceedings of the National Academy of Sciences of the United States of America, 2001
- Radio-responsive recA promoter significantly increases TNFα production in recombinant clostridia after 2 Gy irradiationGene Therapy, 2001
- Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicumCancer Gene Therapy, 2001
- Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumorsCancer Gene Therapy, 2000
- Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironmentGene Therapy, 1997
- Chemotherapeutic tumour targeting using clostridial sporesFEMS Microbiology Reviews, 1995